Results 301 to 310 of about 357,202 (334)
PGXTEC) liquid technology is utilized to develop highly respirable yeast beta‐glucan (YBG) microparticles for the treatment of pulmonary fibrosis. Compared to conventionally processed spray‐dried YBG, PGXTEC‐YBG exhibits greatly improved aerodynamic properties, enhanced pro‐fibrotic macrophage uptake, and effective downregulation of pro‐fibrotic ...
Nate Dowdall+14 more
wiley +1 more source
Advanced Nanoparticle Therapeutics for Targeting Neutrophils in Inflammatory Diseases
This review highlights recent advances in nanoparticle‐based strategies to modulate neutrophil activity in inflammatory diseases. By targeting inflammatory neutrophils, NET formation, and neutrophil apoptosis or recruitment, these approaches aim to improve therapeutic precision.
Min Ji Byun+9 more
wiley +1 more source
Printing and Rerouting of Elastic and Protease Responsive Shape Memory Hydrogel Filaments
A biofabrication strategy, Rerouting of Free‐Floating Suspended Hydrogel Filaments (REFRESH), is developed enabling the printing of highly elastic, reconfigurable protease‐responsive hydrogel filaments with shape memory properties. The filaments can be manually braided, knotted, and rerouted to create intricate cell‐laden 3D architectures, expanding ...
Philip Lifwergren+10 more
wiley +1 more source
Readily UV‐curing and self‐healing methacrylated collagen peptide (COPMA) hydrogels are developed with tunable mechanical properties. As the interpenetrating network between COPMA and xanthan gum (XG), COPMA‐XG bioinks show improved mechanical properties, printability, and stability, compared to COPMA or XG.
Hongjuan Weng+6 more
wiley +1 more source
Inhibitors of human leukocyte proteinase-3 [PDF]
Full text of this article is not available in SOAR.
Groutas, William C.+6 more
openaire +2 more sources
Kinetics of the Inhibition of Proteinase 3 by Elafin [PDF]
Excessive proteolytic activity of proteinase 3 (Pr3) has been suggested to be a factor contributing to the pathogenesis of emphysema and other inflammatory disorders. We report here on the kinetics of inhibition of Pr3 by one of its major endogenous inhibitors, the 6-kD inhibitory domain of elafin.
Sanford R. Simon, Qi-Long Ying
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Proteinase 3. A neutrophil proteinase with activity on platelets.
The Journal of Immunology, 1994Abstract Purified proteinase 3 (PR3) devoid of any elastase (HLE) and cathepsin G (Cat.G) contaminants, was prepared from azurophilic granules of human polymorphonuclear neutrophils by using a novel procedure. Although unable to induce platelet activation (up to 25 micrograms/ml) by itself, PR3 at a concentration as low as 2.5 micrograms/
P, Renesto+4 more
openaire +2 more sources
Proteinase 3 phosphonic inhibitors
Biochimie, 2019Neutrophils are one of the most important military services of the armed forces of the immune system, a crucial line of defense against bacterial or fungal onslaughts. One of their mechanisms of action relies on the production of serine proteases.
Renata Grzywa+3 more
openaire +3 more sources
[3] Myeloblastin: Leukocyte proteinase 3
1994Publisher Summary This chapter describes assay, purification, and properties of myeloblastin. Myeloblastin is a neutral serine endopeptidase produced during myeloid differentiation and stored in the azurophilic granules of polymorphonuclear leukocytes (PMNs).
John R. Hoidal+2 more
openaire +3 more sources